Alkem Laboratories Limited has informed the Exchange regarding a press release dated March 20, 2026, titled "Intimation regarding receipt of EU GMP Certificate for the Company s manufacturing facility located at Daman, India".
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alkem Laboratories has received a Certificate of GMP Compliance for its manufacturing facility located in Daman, India, from the Malta Medicines Authority. The certification follows a GMP inspection conducted on 9th December 2025 at the facility, which was previously intimated to the exchanges. The certificate is valid for a period of three years from the date of inspection. Malta Medicines Authority is an EU regulatory body, so this certification enables Alkem to manufacture and supply pharmaceutical products to European Union markets from this Daman plant.
Positive for shareholders — EU GMP clearance opens the door for Alkem to tap regulated European markets, potentially boosting export revenues and long-term business growth from the Daman facility.